2013 annual financial data

Corcept Therapeutics Incorporated 2013 Operating margin

Corcept Therapeutics Incorporated 2013 operating margin with verified reported…

Direct answer

Operating margin was -400.66%.

Operating income was -41,496,000 USD and net income was -46,011,000 USD.
Operating cash flow was -37,058,000 USD.

Get free Corcept Therapeutics Incorporated email updates.

Bullstory sends one daily email when new analysis or important company news is available.

Verified data

Revenue
10,357,000 USD
Operating income
-41,496,000 USD
Net income
-46,011,000 USD
Operating cash flow
-37,058,000 USD